NCT06483906 2026-03-03
Venetoclax and Azacitidine Combined With Homoharringtonine, Followed by Allo-HSCT for Intermediate and High-risk AML.
Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine
Phase 2 Recruiting
Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine
First Affiliated Hospital of Zhejiang University